A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
Context: The combination of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) is widely used in the treatment of moderate-to-severe asthma uncontrolled by ICS alone. Aims: To evaluate the efficacy and safety of a new ICS-LABA combination inhaler containing Formoterol (F) and Cicleso...
Main Authors: | Sundeep S Salvi, Abhijit J Vaidya, Rahul R Kodgule, Jaideep A Gogtay |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Lung India |
Subjects: | |
Online Access: | http://www.lungindia.com/article.asp?issn=0970-2113;year=2016;volume=33;issue=3;spage=272;epage=277;aulast=Salvi |
Similar Items
-
A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
by: Madhu Sudan Barthwal, et al.
Published: (2017-01-01) -
CICLESONIDE IN TREATMENT OF CHILDHOOD BRONCHIAL ASTHMA
by: K. E. Efendieva, et al.
Published: (2013-02-01) -
Efficacy of ciclesonide in the treatment of patients
with asthma exacerbation
by: Ziemowit Zietkowski, et al.
Published: (2019-05-01) -
Ciclesonide in the treatment of patients with bronchial asthma
by: V. I. Trofimov
Published: (2014-12-01) -
Comparison of Rapid Bronchodilatory Effects of Salmeterol and Formoterol in Patients with Moderate to Severe Asthma
by: Ebrahim Salehifar, et al.
Published: (2015-10-01)